July 25, 2019 Article

Between January 2015 to January 2018, the drugs that multiple sclerosis patients rely on have skyrocketed from $60,000 to close to $100,000. In the last decade, the top three insulin manufacturers — Eli Lilly, Novo Nordisk, and Sanofi — have increased the price of insulin by 700 percent in lockstep as 1 in 4 diabetics rations or forgoes this lifesaving medication due to cost.

September 4, 2018 Article

By Rep. Mark Pocan (D-WI) and Rep. Jan Schakowsky (D-IL) for The Hill

July 30, 2018 Article

By Rep. Jan Schakowsky (D-IL) and Rep. Francis Rooney (R-FL) for CNBC

April 9, 2018 Article

By Rep. Jan Schakowsky for CNBC

Facebook completely failed to protect Americans' data. Is anyone surprised?

October 18, 2017 Article
Originally published in the Huffington Post